Dr. Cameron Ronald John, LICENSED PSYCHOLOGIS Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 3375 W. Mayflower Way, Suite A, Lehi, UT 84043 Phone: 801-331-6775 |
Dr. Jackie Marie Nelson, PSY.D. Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 2250 N Miller Campus Dr, Lehi, UT 84043 Phone: 801-662-1000 |
Jared Moroni Casey Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 121 E State St Ste B, Lehi, UT 84043 Phone: 801-407-9998 |
Jennifer R Roberts, PHD Psychologist - Adult Development & Aging Medicare: Not Enrolled in Medicare Practice Location: 2940 W Maple Loop Dr Ste 303e, Lehi, UT 84043 Phone: 801-641-1798 |
Dr. Rachel Elizabeth Lyon, PHD Psychologist - Counseling Medicare: Accepting Medicare Assignments Practice Location: 3300 N Running Creek Way, Bldg E, #100, Lehi, UT 84043 Phone: 801-380-7000 |
Aimee Noelle Tubbs, ED.S Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 1327 S 100 E Unit 3, Lehi, UT 84043 Phone: 801-310-1303 |
Dr. Suzanne Farnsworth Plowman, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 3300 Running Creek Way, Bldg E, Suite 105, Lehi, UT 84043 Phone: 801-669-8300 |
News Archive
Less than a quarter of Americans want no changes to the health care legislation signed into law by the president last month but there may be more common ground with other Americans than many think, according to the latest national survey by researchers from Indiana University's Center for Health Policy and Professionalism Research.
A study conducted at Columbia University's Mailman School of Public Health found that there were fewer drivers killed in car crashes who tested positive for opioids in states with medical marijuana laws than before the laws went into effect.
The U.S. Food and Drug Administration today held an Endocrinologic and Metabolic Drugs Advisory Committee to review the results of SCOUT and the weight loss medication sibutramine (sold as Meridia® in the United States).
Scientists have uncovered a new target for the potential treatment of TB, finally resolving a long-running debate about how the bacterial cell wall is built.
A new study published on the preprint server medRxiv* in May 2020 reports the beneficial effects of the monoclonal antibody sarilumab in severe COVID-19 pneumonia.
› Verified 3 days ago